Riskpilot← Back to searchSign inGet full accessArisone Medic AB
ABActiveOrg 5592580632ÄngelholmPost-secondary non-tertiary education · NACE 8533Est. 20205-9 employees
Revenue 2025
SEK 748K
+391% vs 2024
EBITDA margin
41.1%
+2780% vs 2024
Equity ratio
71.1%
Financial strength
Net profit 2025
SEK 272K
+2609% vs 2024
| Revenue | SEK 748K | +391% |
| EBITDA | SEK 307K | +2780% |
| Net profit | SEK 272K | +2609% |
| Total assets | SEK 420K | +2284% |
| Equity | SEK 299K | +384% |
| Employees | — | — |
Legal name
Arisone Medic AB
Org number
5592580632
Legal form
Aktiebolag
NACE code
8533 · Post-secondary non-tertiary education
Founded
2 juni 2020
Share capital
SEK 25 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva utbildning för vård och omsorg och kommunal vuxenutbildning på gymnasial nivå samt hemvård med förenlig verksamhet.
Address
Ängelholm
Email
nadmyr@arisone.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 374 | 50 | 0 | 152 | 748 |
| Staff expenses | — | — | −6 | −6 | −220 |
| EBITDA | 25 | −83 | −67 | 11 | 307 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 25 | −83 | −67 | 11 | 307 |
| Net financials | — | — | −0 | −1 | −0 |
| Profit before tax | 25 | −83 | −67 | 10 | 307 |
| Tax | −3 | −0 | — | — | −35 |
| Net profit | 22 | −83 | −67 | 10 | 272 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 141 | 36 | 3 | 18 | 420 |
| Equity | 35 | −48 | −115 | −105 | 299 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 106 | 84 | 118 | 123 | 121 |
| Total debt | 106 | 84 | 118 | 123 | 121 |
EBITDA margin
41.1%
This company
15.8%
Market median
+160% vs market
20212025
Equity ratio
71.1%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
91.1%
This company
18.4%
Market median
+395% vs market
20212025
Net profit margin
36.4%
This company
8.1%
Market median
+349% vs market
20212025
Asset turnover
1.78×
This company
1.12×
Market median
+59% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AE Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Arisone Medic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Elisabet Katarina Nadmyr | Chief Executive Officer | 0 companies |
| Abbas Ali Nadmyr | Deputy Board Member | 0 companies |
| Iris Svensson | Board of Directors | 0 companies |